College of Pharmaceutical Science, Zhejiang University of Technology, Chaowang Road 18, Hangzhou, 310014, People's Republic of China.
Tianjin Engineering Research Center of Microbial Metabolism and Fermentation Process Control, Tianjin, 300457, China.
Appl Microbiol Biotechnol. 2020 Jul;104(14):6161-6172. doi: 10.1007/s00253-020-10679-9. Epub 2020 May 21.
Galacto-oligosaccharides (GOS), which can be produced by enzymatic transgalactosylation of lactose with β-galactosidases, have attracted much attention in recent years because of their prebiotic functions and wide uses in infant formula, infant foods, livestock feed, and pet food industries. In this study, a novel β-galactosidase-producing Klebsiella oxytoca ZJUH1705, identified by its 16S rRNA sequence (GenBank accession no. MH981243), was isolated. Two β-galactosidase genes, bga 1 encoding a 2058-bp fragment (GenBank accession no. MH986613) and bga 2 encoding a 3108-bp fragment (GenBank accession no. MN182756), were cloned from K. oxytoca ZJUH1705 and expressed in E. coli. The purified β-gal 1 and β-gal 2 had the specific activity of 217.56 U mg and 57.9 U mg, respectively, at the optimal pH of 7.0. The reaction kinetic parameters K, V, and K with oNPG as the substrate at 40 °C were 5.62 mM, 167.1 μmol mg min, and 218.1 s, respectively, for β-gal 1 and 3.91 mM, 14.6 μmol mg min, and 28.9 s, respectively, for β-gal 2. Although β-gal 1 had a higher enzyme activity for lactose hydrolysis, only β-gal 2 had a high transgalactosylation capacity. Using β-gal 2 with the addition ratio of ~ 2.5 U g lactose, a high GOS yield of 45.5 ± 2.3% (w/w) was obtained from lactose (40% w/w or 480 g L) in a phosphate buffer (100 mM, pH 7.0) at 40 °C in 48 h. Thus, the β-gal 2 from K. oxytoca ZJUH1705 would be a promising biocatalyst for GOS production from lactose.Key Points• A novel bacterial β-galactosidase producer was isolated and identified.• β-Galactosidases were cloned and expressed in heterologous strain and characterized.• Both enzymes have hydrolytic activity but only one have transglycosilation activity.• The developed process with β-gal 2 could provide an alternative for GOS production.
半乳糖寡糖(GOS)可以通过β-半乳糖苷酶对乳糖的酶促转糖苷作用生成,由于其具有益生元功能以及在婴儿配方奶粉、婴儿食品、牲畜饲料和宠物食品工业中的广泛用途,近年来受到了广泛关注。在本研究中,通过 16S rRNA 序列(GenBank 登录号:MH981243)鉴定了一种新型β-半乳糖苷酶产生菌,名为产酸克雷伯氏菌 ZJUH1705。从产酸克雷伯氏菌 ZJUH1705 中克隆了两个β-半乳糖苷酶基因,bga1 编码 2058bp 片段(GenBank 登录号:MH986613)和 bga2 编码 3108bp 片段(GenBank 登录号:MN182756),并在大肠杆菌中进行了表达。纯化的β-gal1 和β-gal2 在最佳 pH 值 7.0 时的比活性分别为 217.56 U mg 和 57.9 U mg。以 oNPG 为底物,在 40°C 时β-gal1 的 K、V 和 K 值分别为 5.62 mM、167.1 μmol mg min 和 218.1 s,β-gal2 的 K、V 和 K 值分别为 3.91 mM、14.6 μmol mg min 和 28.9 s。尽管β-gal1 对乳糖水解具有更高的酶活性,但只有β-gal2 具有较高的转糖苷能力。在添加比例约为 2.5 U g 乳糖的情况下,使用β-gal2,在 40°C 下,在 48 小时内,从 40%(w/w)或 480 g L 的乳糖(磷酸盐缓冲液 100 mM,pH 7.0)中可获得 45.5±2.3%(w/w)的高 GOS 产率。因此,产酸克雷伯氏菌 ZJUH1705 的β-gal2 有望成为从乳糖生产 GOS 的有前途的生物催化剂。